Searched for
JUBILANT PHARMA HOLDINGS
USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...- JioBlackRock Flexi Cap Fund exits 3 AMC stocks, HAL, and 13 others in AprilJioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Coca-Cola, Jubilant to step up focus on profitability, costsThe Jubilant Bhartia Group on July 23 announced that group company Jubilant Beverages closed the acquisition of a 40% stake in Hindustan Co...
- Jubilant promoters eye Rs 2,000 crore via stake sales for Hindustan Coca-Cola Beverages dealJubilant Bhartia Group's promoters are selling minority stakes in listed companies to raise ₹2,000 crore for partially funding the acquisit...
- Hot Stocks: Brokerages on Jubilant FoodWorks, Sun Pharma, Nykaa; Motilal upgrades HDFC LifeTop brokerages issue ratings and targets for key stocks: Motilal Oswal upgrades HDFC Life to buy; Jefferies reaffirms buy for Sun Pharma; U...
- Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and othersResults that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings ...
- Jubilant Pharma arm to raise USD 400 million loan from Standard Chartered Bank to repay debtWhile the term loan and bonds aggregate to USD 350 million, about Rs 2,787 crore, the company is raising another tranche of USD 50 million ...
- Aurobindo, Sun Pharma recall products in US marketWhile Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Phar...
- Lupin, Sun Pharma, Jubilant Cadista recall drugs in US marketAccording to the USFDA, the company is recalling the affected lot for being "Superpotent". The affected lot has been manufactured at Lupin'...
- Hold Jubilant Life Sciences, target price Rs 822: ICICI SecuritiesJubilant Life Sciences Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 12571.26 Crore) operating in Ph...
- Stock pick of the week: Jubilant Life Sciences offers long-term growth say analystsSharp stock price correction, strong growth rates, focus on the growing speciality pharma segment, a bouquet of niche products, among other...
- Jubilant FoodWorks slips despite promoters backtracking on royalty decisionShares of Jubilant FoodWorks opened at Rs 1341.95 on BSE against its previous closing of Rs 1303.25.
- Stock pick of the week: What makes Jubilant Life Sciences analysts top betBetter than expected 4th quarter results, improving pharma business, launch of new products, debt reduction and reasonable valuations have ...
- Jubilant Life to buy Triad Isotopes' radio-pharmacy businessThe acquisition will be funded through JPL's internal accruals and is likely to be earnings accretive in the first full year of operations,...
- Reasonable valuations make Jubilant Life Sciences stock analysts' favouriteA 65% y-o-y increase in net profit, approvals for new generic drug applications, reduction in debt, and resonable valuations have made the ...
- Jubilant acquires all outstanding shares of Cadista HoldingsJubilant Generics Inc had commenced the open offer to acquire all outstanding shares of the US-based Cadista Holdings Inc in November.
- Sun Pharma tops domestic drugmakers' list; Cipla and Ranbaxy slip two positions eachMumbai-based Sun Pharma has made it to the top of the domestic drug makers’ leaderboard through overseas acquisitions and quadrupling of re...
- Jubilant Life to consolidate pharma business under Singapore unitThe company's board has approved a proposal to transfer its active pharmaceutical ingredient and dosage form business to its Singapore-base...
- Jubilant Life is likely to do well in future on new launches, changes in pricingJubilant Life is quoting at a deep discount to its peers for the past few years because of its volatile earnings and high leverage.
Load More
